Fulminant Hepatitis as a Consequence of Reactivation of Hepatitis B Virus Infection after Discontinuation of Low-Dose Methotrexate Therapy
Authors:
- Jenny HeathcoteJHJenny Heathcote
- Ian R. WanlessIWIan R. Wanless
- Morris ShermanMSMorris Sherman
- William J. ReynoldsWRWilliam J. Reynolds
- Ross G. CameronRCRoss G. Cameron
- Gary A. LevyGLGary A. Levy
- Robert D. InmanRIRobert D. Inman
- 1 March 1990
- journal article
- case report
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 112 (5) , 381-382
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1988
- Comparative effects on the immune system of methotrexate and trimetrexateInternational Journal of Immunopharmacology, 1987
- Hepatotoxicity Associated with Low-dose, Long-term Methotrexate Treatment of Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1987
- FULMINANT HEPATIC FAILURE IN AN HBsAg CARRIER RENAL TRANSPLANT PATIENT FOLLOWING CESSATION OF IMMUNOSUPPRESSIVE THERAPYTransplantation, 1985
- Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritisDigestive Diseases and Sciences, 1985
- Reactivation of Chronic Hepatitis B Virus Infection by Cancer ChemotherapyAnnals of Internal Medicine, 1982
- Methotrexate guidelines—revisedJournal of the American Academy of Dermatology, 1982
- Deleterious Effect of Prednisolone in HBsAg-positive Chronic Active HepatitisNew England Journal of Medicine, 1981
- FULMINANT HEPATIC FAILURE IN LEUKAEMIA AND CHORIOCARCINOMA RELATED TO WITHDRAWAL OF CYTOTOXIC DRUG THERAPYThe Lancet, 1975
- Serial Studies of Hepatitis-Associated Antigen and Antibody in Patients Receiving Antitumor Chemotherapy for Myeloproliferative and Lymphoproliferative DisordersGastroenterology, 1975